Uncategorized
VIDEO: Ocular Therapeutix sees increased enthusiasm for Dextenza
In this Healio Video Perspective, Antony Mattessich, president and CEO of Ocular Therapeutix, discusses the continuing development of Dextenza (dexamethasone ophthalmic insert 0.4 mg).